CVR: 37134120
RetiPharma IVS was a Danish company of the type Iværksætterselskab based in København N, founded in 2015 and dissolved in 2020. The company was registered under the industry Anden teknisk rådgivning. The company has 4 employees. In 2018, the company reported a gross profit of DKK -147,051 and a net result of DKK -203,870 compared with DKK 0 the year before. Equity amounted to DKK -190,437.
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorScreen owners and management against the Danish FSA's official PEP lists
As of September 25, 2020, inforevision statsautoriseret revisionsaktieselskab has stepped down as auditor of RetiPharma IVS.
As of September 25, 2020, Anders Rubinstein has stepped down as liquidator of RetiPharma IVS.
On September 25, 2020, RetiPharma IVS exited liquidation.
RetiPharma IVS was dissolved on September 25, 2020.
As of November 22, 2019, Jørgen Axel Thorball has left the board of directors of RetiPharma IVS.
As of November 22, 2019, Casper Tind Hansen has left the board of directors of RetiPharma IVS.
As of November 22, 2019, David Paul Drucker Woldbye has left the board of directors of RetiPharma IVS.
As of November 22, 2019, Anders Rubinstein is registered as liquidator of RetiPharma IVS.
As of November 22, 2019, Line Hartvig has stepped down as adm. dir. of RetiPharma IVS.
As of November 22, 2019, Morten Albrechtsen has stepped down as chairman of RetiPharma IVS.
On November 22, 2019, RetiPharma IVS entered liquidation.
RetiPharma IVS has published its annual report for 2018. Gross profit came to DKK -147,051, and the net result was DKK -203,870.
As of June 1, 2019, Line Hartvig is registered as adm. dir. of RetiPharma IVS.
As of June 1, 2019, Henrik Vissing has stepped down as adm. dir. of RetiPharma IVS.
As of August 30, 2018, inforevision statsautoriseret revisionsaktieselskab has been appointed auditor of RetiPharma IVS.
RetiPharma IVS has published its annual report for 2017. Revenue came to DKK 0, and the net result was DKK 0.
As of April 16, 2018, Jørgen Axel Thorball has joined the board of directors of RetiPharma IVS.
As of April 16, 2018, Casper Tind Hansen has joined the board of directors of RetiPharma IVS.
As of April 16, 2018, David Paul Drucker Woldbye has joined the board of directors of RetiPharma IVS.
As of April 16, 2018, Henrik Vissing is registered as adm. dir. of RetiPharma IVS.
As of April 16, 2018, Morten Albrechtsen is registered as chairman of RetiPharma IVS.
As of April 16, 2018, Kristian Klemp has stepped down as director of RetiPharma IVS.
As of April 16, 2018, David Paul Drucker Woldbye has stepped down as adm. dir. of RetiPharma IVS.
RetiPharma IVS has published its interim report for the period September 10, 2015 – December 31, 2016.
As of October 4, 2017, Kristian Klemp is registered as director of RetiPharma IVS.
As of October 4, 2017, David Paul Drucker Woldbye is registered as adm. dir. of RetiPharma IVS.
As of August 31, 2017, Kristian Klemp has stepped down as director of RetiPharma IVS.
As of August 31, 2017, David Paul Drucker Woldbye has stepped down as adm. dir. of RetiPharma IVS.
As of September 10, 2015, Kristian Klemp is registered as director of RetiPharma IVS.
As of September 10, 2015, David Paul Drucker Woldbye is registered as adm. dir. of RetiPharma IVS.
RetiPharma IVS was founded on September 10, 2015.
Companies in the same industry and area
CVR 41962712
CVR 44008068
CVR 55352755
CVR 15514701
CVR 43523333
companydata.dk